USP drug classification [BR:br08302]
Antineoplastics
Molecular Target Inhibitors
Phosphatidylinositol-3-Kinase (PI3K) Inhibitors
Inavolisib
D11942 Inavolisib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03139 PI3K inhibitor
D11942 Inavolisib
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Phosphotransferase
PIK3CA
D11942 Inavolisib (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11942
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11942